Jan 26, 2024 · Company Overview. Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB) is a leader in precision medicine with immuno-targeted products designed to ...
People also ask
What happened to Navidea Biopharmaceuticals?
NYSE American: NAVB. Price. $0.04. Change. 0.00 (1.90%). Volume. 3.14k. Day Range. 0.04 - 0.04. Year Range. 0.06 - 0.35. View Investor Relations View Investor ...
Navidea Biopharmaceuticals (NAVB) Investor Presentation - Slideshow · SA TranscriptsFri, Jan. 15, 2021. Navidea Biopharmaceuticals, Inc. (NAVB) CEO Jed Latkin ...
A high-level overview of Navidea Biopharmaceuticals, Inc. (NAVB) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, ...
Stock Purchase Agreement and Letter of Investment Intent, dated August 31, 2020, by and between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, ...
Investor Relations. T: (614) 822-2322 investorrelations@navidea.com. Management Team. Michael Blue, M.D., FACEP. Chief Medical Officer. Craig A. Dais, CPA.
Most Recent Insider Transactions ; Date Type ; Shareholder Title ; Transaction Type Share Price ; Shares Value ...